首页> 外文期刊>Neurobiology of disease >Increased protein kinase C gamma activity induces Purkinje cell pathology in a mouse model of spinocerebellar ataxia 14
【24h】

Increased protein kinase C gamma activity induces Purkinje cell pathology in a mouse model of spinocerebellar ataxia 14

机译:蛋白激酶Cγ活性增加会在脊髓小脑性共济失调的小鼠模型中诱发浦肯野细胞病理学14

获取原文
获取原文并翻译 | 示例
           

摘要

Spinocerebellar ataxias (SCAs) are hereditary diseases leading to Purkinje cell degeneration and cerebellar dysfunction. Most forms of SCA are caused by expansion of CAG repeats similar to other polyglutamine disorders such as Huntington's disease. In contrast, in the autosomal dominant SCA-14 the disease is caused by mutations in the protein kinase C gamma (PKCgamma) gene which is a well characterized signaling molecule in cerebellar Purkinje cells. The study of SCA-14, therefore, offers the unique opportunity to reveal the molecular and pathological mechanism eventually leading to Purkinje cell dysfunction and degeneration. We have created a mouse model of SCA-14 in which PKCgamma protein with a mutation found in SCA-14 is specifically expressed in cerebellar Purkinje cells. We find that in mice expressing the mutated PKCgamma protein the morphology of Purkinje cells in cerebellar slice cultures is drastically altered and mimics closely the morphology seen after pharmacological PKC activation. Similar morphological abnormalities were seen in localized areas of the cerebellum of juvenile transgenic mice in vivo. In adult transgenic mice there is evidence for some localized loss of Purkinje cells but there is no overall cerebellar atrophy. Transgenic mice show a mild cerebellar ataxia revealed by testing on the rotarod and on the walking beam. Our findings provide evidence for both an increased PKCgamma activity in Purkinje cells in vivo and for pathological changes typical for cerebellar disease thus linking the increased and dysregulat-ed activity of PKCgamma tightly to the development of cerebellar disease in SCA-14 and possibly also in other forms of SCA.
机译:脊髓小脑共济失调(SCAs)是导致浦肯野细胞变性和小脑功能障碍的遗传性疾病。多数形式的SCA是由CAG重复序列的扩增引起的,类似于其他亨廷顿氏病等其他聚谷氨酰胺疾病。相比之下,在常染色体显性SCA-14中,该疾病是由蛋白激酶C伽玛(PKCgamma)基因的突变引起的,该基因是小脑Purkinje细胞中一个很好表征的信号分子。因此,SCA-14的研究为揭示最终导致浦肯野细胞功能障碍和变性的分子和病​​理机制提供了独特的机会。我们创建了SCA-14小鼠模型,其中在SCA-14中发现具有突变的PKCgamma蛋白在小脑浦肯野细胞中特异性表达。我们发现,在表达突变的PKCgamma蛋白的小鼠中,小脑切片培养物中Purkinje细胞的形态发生了巨大变化,并紧密模拟了药理PKC激活后所见的形态。在体内少年转基因小鼠小脑的局部区域中观察到类似的形态异常。在成年转基因小鼠中,有证据表明浦肯野细胞有一些局部丢失,但没有整体小脑萎缩。转基因小鼠在旋转脚架和步行梁上进行测试后显示出轻度小脑共济失调。我们的发现为体内浦肯野细胞中PKCgamma活性增加和小脑疾病典型的病理变化提供了证据,从而将PKCgamma活性的增加和调节异常与SCA-14以及其他可能的小脑疾病的发展紧密相关。 SCA的形式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号